Efficacy and Safety of Recombinant Human Adenovirus Type 5 (H101) in Persistent, Recurrent, or Metastatic Gynecologic Malignancies: A Retrospective Study

BACKGROUND: To assess the efficacy and safety of recombinant human adenovirus type 5 (H101) in patients with persistent, recurrent, or metastatic gynecologic malignancies. METHODS: The study retrospectively enrolled patients with persistent/recurrent/metastatic gynecologic malignancies who received...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jing, Zhang, Qiying, Liu, Zi, Wang, Juan, Shi, Fan, Su, Jin, Wang, Tao, Wang, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095970/
https://www.ncbi.nlm.nih.gov/pubmed/35574359
http://dx.doi.org/10.3389/fonc.2022.877155

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095970/
https://www.ncbi.nlm.nih.gov/pubmed/35574359
http://dx.doi.org/10.3389/fonc.2022.877155

Ejemplares similares